ILKAP通过调节PGAM1-介导的糖分分解重编程来驱动肝细胞癌的进展
Juejiashan Li1, Yihong Chen1, Qiyi Qian1
1School of Basic Medical Sciences & Forensic Medicine, Hangzhou Medical college, Hangzhou, 310053, China.
Frontiers of medicine
|December 26, 2025
概括
整合素结合酶相关酸酶 (ILKAP) 通过改变糖解和PGAM1表达来驱动肝细胞癌 (HCC) 的进展. 准ILKAP为肝癌治疗提供了一个潜在的新策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
- 对于有效的HCC治疗,迫切需要新的治疗点.
- 整合素连接酶相关酸酶 (ILKAP) 在HCC发病过程中的作用在很大程度上尚未被探索.
研究的目的:
- 研究ILKAP在肝细胞癌 (HCC) 中的致癌作用.
- 阐明ILKAP对HCC进展作出贡献的分子机制.
- 评估ILKAP作为肝癌的潜在治疗点.
主要方法:
- 癌症基因组图谱 (TCGA) 和UALCAN数据库对HCCILKAP表达的生物信息分析.
- 在体外功能测定 (细胞增殖,迁移) 和体内异种移植模型,以评估ILKAP对HCC的影响.
- 在ILKAP沉默时,RNA测序以识别差异表达基因 (DEG),重点关注代谢途径.
- 在HCC组织中ILKAP和PGAM1表达之间的相关性分析和代谢重编程标志物的评估.
主要成果:
- 在HCC中ILKAP过度表达,并与患者预后不佳有关.
- ILKAP knockdown 抑制了HCC细胞的增殖,迁移和瘤的生长.
- ILKAP沉默降低了糖解酶PGAM1的调节,这对ILKAP介导的瘤进展至关重要.
- ILKAP调节HCC细胞中的代谢重编程,影响糖解和相关的基因表达.
结论:
- 通过调节PGAM1和糖解,ILKAP促进肝细胞癌 (HCC) 恶性瘤.
- ILKAP-PGAM1轴代表了HCC发展和进展的重要途径.
- 伊尔卡普是开发肝癌管理新策略的有前途的治疗点.
更多相关视频
07:08Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.3K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.5K
相关概念视频
01:24Liver Regeneration
4.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.2K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K